Genomma Lab Internacional, S.A.B. de C.V (LABB.MX) Financial Statements
Price: $24.73
Market Cap: $24.73B
Avg Volume: 3.31M
Market Cap: $24.73B
Avg Volume: 3.31M
Country: MX
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Overview of Financial Statements
Financial statements are records that provide an overview of a company's financial performance and position. There are three main types of financial statements:
- Income Statement: Shows the company's revenue, expenses, and profit over a specific period.
- Balance Sheet: Provides a snapshot of the company's assets, liabilities, and equity at a specific point in time.
- Cash Flow Statement: Details the cash inflows and outflows from operating, investing, and financing activities over a period.
This page presents both annual and quarterly data for these financial statements. The charts below provide a visual representation of the key metrics from each statement, helping you to quickly understand the financial health of Genomma Lab Internacional, S.A.B. de C.V.
Income Statement
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 | December 31, 2018 | December 31, 2017 | December 31, 2016 | December 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $18.61B | $16.47B | $16.82B | $15.49B | $13.87B | $12.71B | $11.79B | $12.08B | $11.32B | $11.04B |
| Cost of Revenue | $6.68B | $6.38B | $6.66B | $5.92B | $5.28B | $4.61B | $4.03B | $3.96B | $3.64B | $3.78B |
| Gross Profit | $11.93B | $10.08B | $10.16B | $9.56B | $8.59B | $8.10B | $7.76B | $8.12B | $7.68B | $7.27B |
| Gross Profit Ratio | 64.12% | 61.20% | 60.43% | 61.70% | 61.92% | 63.70% | 65.83% | 67.24% | 67.88% | 65.80% |
| Research and Development Expenses | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| General and Administrative Expenses | $7.65B | $6.84B | $6.92B | $6.57B | $5.67B | $5.82B | $5.58B | $5.62B | $7.49B | $7.33B |
| Selling and Marketing Expenses | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Selling General and Administrative Expenses | $7.65B | $6.84B | $6.92B | $6.57B | $5.67B | $5.82B | $5.58B | $5.62B | $7.49B | $7.33B |
| Other Expenses | $301.33M | $-14.68M | $2.29M | $63.44M | $-153.09M | $57.53M | $237.54M | $39.85M | $-86.68M | $-906.46M |
| Operating Expenses | $7.95B | $6.82B | $6.92B | $6.57B | $5.67B | $5.82B | $5.58B | $5.62B | $7.39B | $7.33B |
| Cost and Expenses | $14.62B | $13.21B | $13.58B | $12.49B | $10.95B | $10.44B | $9.61B | $9.58B | $11.03B | $11.11B |
| Interest Income | $106.11M | $156.93M | $118.05M | $65.43M | $31.40M | $28.78M | $31.77M | $40.09M | $33.24M | $20.59M |
| Interest Expense | $887.80M | $829.90M | $525.64M | $444.39M | $461.11M | $606.68M | $554.63M | $483.52M | $329.94M | $392.56M |
| Depreciation and Amortization | $359.59M | $227.30M | $227.12M | $170.27M | $158.99M | $142.20M | $81.16M | $69.81M | $83.81M | $118.23M |
| EBITDA | $4.14B | $2.82B | $3.01B | $2.84B | $3.04B | $2.29B | $2.40B | $2.72B | $-1.10B | $-943.89M |
| EBITDA Ratio | 22.24% | 17.14% | 20.23% | 20.51% | 21.89% | 19.12% | 22.06% | 22.57% | 7.52% | -0.35% |
| Operating Income | $3.98B | $3.26B | $3.25B | $3.05B | $2.77B | $2.33B | $2.30B | $2.53B | $-1.67B | $-975.22M |
| Operating Income Ratio | 21.40% | 19.80% | 19.29% | 19.67% | 19.96% | 18.33% | 19.51% | 20.96% | -14.73% | -8.83% |
| Total Other Income Expenses Net | $-1.09B | $-1.54B | $-988.36M | $-824.67M | $-597.67M | $-785.49M | $-537.66M | $-366.19M | $150.65M | $-479.46M |
| Income Before Tax | $2.89B | $1.72B | $2.26B | $2.22B | $2.24B | $1.56B | $1.76B | $2.17B | $-1.52B | $-1.45B |
| Income Before Tax Ratio | 15.54% | 10.45% | 13.42% | 14.35% | 16.13% | 12.27% | 14.95% | 17.93% | -13.40% | -13.17% |
| Income Tax Expense | $753.78M | $635.67M | $867.61M | $914.01M | $766.83M | $795.73M | $653.98M | $758.70M | $126.48M | $-373.89M |
| Net Income | $2.14B | $1.08B | $1.39B | $1.31B | $1.40B | $764.46M | $1.11B | $1.28B | $-1.68B | $-1.07B |
| Net Income Ratio | 11.49% | 6.59% | 8.26% | 8.44% | 10.12% | 6.01% | 9.41% | 10.59% | -14.85% | -9.68% |
| EPS | $2.26 | $1.13 | $1.40 | $1.30 | $1.39 | $0.75 | $1.08 | $1.34 | $-1.71 | $-1.04 |
| EPS Diluted | $2.26 | $1.13 | $1.40 | $1.30 | $1.39 | $0.75 | $1.08 | $1.34 | $-1.71 | $-1.04 |
| Weighted Average Shares Outstanding | 944.86M | 957.34M | 993.23M | 1.01B | 1.01B | 1.01B | 1.02B | 952.49M | 980.81M | 1.03B |
| Weighted Average Shares Outstanding Diluted | 944.86M | 957.34M | 993.23M | 1.01B | 1.01B | 1.01B | 1.02B | 952.49M | 980.81M | 1.03B |
| SEC Filing | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source |
Balance Sheet
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 | December 31, 2018 | December 31, 2017 | December 31, 2016 | December 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and Cash Equivalents | $2.38B | $1.47B | $1.50B | $1.22B | $2.05B | $899.66M | $1.39B | $1.07B | $1.85B | $1.67B |
| Short Term Investments | $- | $183.23M | $205.93M | $- | $- | $- | $- | $- | $-50.31M | $-945.05M |
| Cash and Short Term Investments | $2.38B | $1.66B | $1.50B | $1.22B | $2.05B | $899.66M | $1.39B | $1.07B | $1.85B | $1.67B |
| Net Receivables | $- | $- | $- | $- | $- | $- | $23.27M | $- | $-23.20M | $- |
| Inventory | $2.18B | $1.91B | $2.40B | $2.20B | $2.05B | $1.91B | $1.70B | $1.26B | $1.17B | $1.16B |
| Other Current Assets | $7.84B | $7.10B | $7.42B | $8.21B | $8.05B | $7.01B | $5.89B | $5.51B | $4.80B | $4.71B |
| Total Current Assets | $12.40B | $10.67B | $11.31B | $11.52B | $12.04B | $9.82B | $9.00B | $7.84B | $7.80B | $7.54B |
| Property Plant Equipment Net | $3.56B | $3.41B | $3.59B | $3.37B | $2.85B | $2.22B | $1.87B | $548.65M | $368.63M | $406.64M |
| Goodwill | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Intangible Assets | $5.93B | $4.96B | $5.15B | $5.17B | $4.91B | $4.91B | $4.93B | $5.18B | $5.21B | $7.06B |
| Goodwill and Intangible Assets | $5.93B | $4.96B | $5.15B | $5.17B | $4.91B | $4.91B | $4.93B | $5.18B | $5.21B | $7.06B |
| Long Term Investments | $- | $545.92M | $787.75M | $765.00M | $1.70B | $1.63B | $1.56B | $1.47B | $1.47B | $2.30B |
| Tax Assets | $1.65B | $611.61M | $593.93M | $500.76M | $540.11M | $576.44M | $624.89M | $681.99M | $817.82M | $323.44M |
| Other Non-Current Assets | $538.00M | $534.21M | $168.90M | $220.88M | $93.52M | $92.08M | $94.34M | $160.56M | $44.19M | $2.46M |
| Total Non-Current Assets | $11.68B | $10.07B | $10.29B | $10.02B | $10.10B | $9.44B | $9.08B | $8.05B | $7.91B | $10.09B |
| Other Assets | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Assets | $24.08B | $20.74B | $21.61B | $21.54B | $22.13B | $19.25B | $18.08B | $15.89B | $15.71B | $17.63B |
| Account Payables | $1.74B | $1.84B | $1.79B | $1.44B | $1.64B | $1.88B | $1.77B | $1.10B | $1.03B | $670.12M |
| Short Term Debt | $- | $2.01B | $4.85B | $2.11B | $2.01B | $1.57B | $676.02M | $3.01B | $2.07B | $350.88M |
| Tax Payables | $367.69M | $880.93M | $1.04B | $1.25B | $275.79M | $194.31M | $168.18M | $336.37M | $129.06M | $184.28M |
| Deferred Revenue | $- | $- | $- | $- | $- | $- | $- | $- | $1.99B | $1.45B |
| Other Current Liabilities | $4.65B | $1.90B | $1.68B | $1.78B | $2.69B | $2.03B | $1.87B | $1.86B | $1.86B | $1.29B |
| Total Current Liabilities | $6.75B | $6.62B | $9.36B | $6.57B | $6.61B | $5.68B | $4.49B | $6.31B | $5.10B | $2.50B |
| Long Term Debt | $5.06B | $4.23B | $1.59B | $3.86B | $4.47B | $4.53B | $5.20B | $1.69B | $3.76B | $5.83B |
| Deferred Revenue Non-Current | $- | $- | $- | $- | $- | $- | $- | $- | $48.74M | $54.44M |
| Deferred Tax Liabilities Non-Current | $- | $326.36M | $392.73M | $554.70M | $551.64M | $214.82M | $100.37M | $1.69M | $2.27M | $1.70M |
| Other Non-Current Liabilities | $676.04M | $114.50M | $115.08M | $489.14M | $858.28M | $856.45M | $866.40M | $840.27M | $3.85M | $3.07M |
| Total Non-Current Liabilities | $5.74B | $4.67B | $2.10B | $4.90B | $5.88B | $5.60B | $6.16B | $2.53B | $3.82B | $5.89B |
| Other Liabilities | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Liabilities | $12.49B | $11.30B | $11.45B | $11.47B | $12.50B | $11.28B | $10.65B | $8.84B | $8.92B | $8.38B |
| Preferred Stock | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Common Stock | $1.83B | $1.86B | $1.91B | $1.91B | $1.91B | $1.91B | $1.91B | $1.91B | $1.91B | $1.91B |
| Retained Earnings | $12.21B | $10.83B | $10.05B | $9.42B | $8.88B | $7.48B | $6.81B | $5.99B | $5.51B | $7.20B |
| Accumulated Other Comprehensive Income Loss | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Other Total Stockholders Equity | $-2.45B | $-3.25B | $-2.13B | $-1.26B | $-1.95B | $-1.42B | $-1.29B | $-1.06B | $-847.55M | $-121.46M |
| Total Stockholders Equity | $11.59B | $9.44B | $10.15B | $10.07B | $9.63B | $7.97B | $7.43B | $6.85B | $6.58B | $8.99B |
| Total Equity | $11.59B | $9.44B | $10.15B | $10.07B | $9.63B | $7.97B | $7.43B | $7.05B | $6.79B | $9.25B |
| Total Liabilities and Stockholders Equity | $24.08B | $20.74B | $21.61B | $21.54B | $22.13B | $19.25B | $18.08B | $15.89B | $15.71B | $17.63B |
| Minority Interest | $- | $- | $- | $- | $- | $- | $- | $201.90M | $212.03M | $260.75M |
| Total Liabilities and Total Equity | $24.08B | $20.74B | $21.61B | $21.54B | $22.13B | $19.25B | $18.08B | $15.89B | $15.71B | $17.63B |
| Total Investments | $- | $729.15M | $787.75M | $765.00M | $1.70B | $1.63B | $1.56B | $1.47B | $1.42B | $1.35B |
| Total Debt | $5.06B | $6.24B | $6.44B | $5.96B | $6.48B | $6.10B | $5.87B | $4.70B | $5.83B | $6.18B |
| Net Debt | $2.69B | $4.77B | $4.94B | $4.74B | $4.43B | $5.20B | $4.48B | $3.63B | $3.99B | $4.51B |
Cash Flow Statement
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 | December 31, 2018 | December 31, 2017 | December 31, 2016 | December 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $2.14B | $1.08B | $1.39B | $1.31B | $1.47B | $764.46M | $1.11B | $1.41B | $-1.52B | $-1.45B |
| Depreciation and Amortization | $359.59M | $227.30M | $227.12M | $170.27M | $158.99M | $142.20M | $81.16M | $69.81M | $83.81M | $118.23M |
| Deferred Income Tax | $- | $- | $- | $- | $- | $- | $75.11M | $- | $- | $- |
| Stock Based Compensation | $- | $- | $- | $- | $- | $- | $5.23M | $- | $- | $- |
| Change in Working Capital | $-529.33M | $458.66M | $-273.61M | $-811.40M | $-434.17M | $-932.56M | $-280.46M | $-875.55M | $1.00B | $718.49M |
| Accounts Receivables | $-592.72M | $66.34M | $- | $- | $- | $- | $- | $- | $- | $- |
| Inventory | $-242.70M | $-164.18M | $-434.59M | $-227.60M | $-227.55M | $-359.90M | $-411.87M | $-92.17M | $-13.13M | $436.10M |
| Accounts Payables | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Other Working Capital | $306.09M | $556.50M | $160.99M | $-583.80M | $-206.62M | $-572.66M | $131.41M | $-783.38M | $1.01B | $282.39M |
| Other Non Cash Items | $1.05B | $476.14M | $712.07M | $801.62M | $519.33M | $1.03B | $571.97M | $819.33M | $2.11B | $940.26M |
| Net Cash Provided by Operating Activities | $3.02B | $2.25B | $2.05B | $1.47B | $1.71B | $1.01B | $1.56B | $1.42B | $1.67B | $322.30M |
| Investments in Property Plant and Equipment | $-227.52M | $- | $-19.47M | $-206.58M | $-7.78M | $-876.60M | $-1.51B | $-311.34M | $-158.12M | $-127.99M |
| Acquisitions Net | $- | $- | $- | $- | $- | $- | $107.34M | $54.54M | $150.00M | $1.90B |
| Purchases of Investments | $-1.57M | $-144.90M | $-205.93M | $- | $- | $- | $- | $- | $- | $- |
| Sales Maturities of Investments | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Other Investing Activities | $-584.13M | $-157.31M | $-262.82M | $-559.04M | $-655.87M | $31.96M | $38.04M | $-39.82M | $69.52M | $-119.47M |
| Net Cash Used for Investing Activities | $-813.23M | $-302.21M | $-282.30M | $-765.62M | $-663.65M | $-844.64M | $-1.37B | $-248.16M | $106.89M | $1.73B |
| Debt Repayment | $124.62M | $-89.07M | $490.99M | $-522.44M | $432.45M | $150.56M | $1.16B | $-1.14B | $-350.31M | $-718.98M |
| Common Stock Issued | $11.11M | $1.74B | $471.15M | $76.90M | $283.33M | $6.75M | $- | $- | $- | $- |
| Common Stock Repurchased | $- | $-1.90B | $-994.92M | $-155.81M | $-15.44M | $-90.90M | $-133.93M | $-4.01M | $-1.08B | $-524.73M |
| Dividends Paid | $-778.82M | $-580.70M | $-777.66M | $-391.76M | $- | $- | $- | $- | $- | $- |
| Other Financing Activities | $-947.95M | $-844.78M | $-551.95M | $-476.14M | $-510.50M | $-688.65M | $-554.63M | $-554.46M | $-323.54M | $-337.86M |
| Net Cash Used Provided by Financing Activities | $-1.59B | $-1.68B | $-1.36B | $-1.47B | $189.85M | $-622.24M | $472.90M | $-1.69B | $-1.75B | $-1.58B |
| Effect of Forex Changes on Cash | $90.82M | $-77.59M | $-171.06M | $-72.54M | $-59.79M | $-31.75M | $-346.58M | $-230.91M | $89.58M | $74.69M |
| Net Change in Cash | $684.34M | $190.39M | $239.04M | $-839.04M | $1.18B | $-491.70M | $321.90M | $-753.49M | $120.33M | $543.61M |
| Cash at End of Period | $2.36B | $1.49B | $1.50B | $1.26B | $2.10B | $922.94M | $1.41B | $1.09B | $1.85B | $1.73B |
| Cash at Beginning of Period | $1.67B | $1.30B | $1.26B | $2.10B | $922.94M | $1.41B | $1.09B | $1.85B | $1.73B | $1.18B |
| Operating Cash Flow | $3.02B | $2.25B | $2.05B | $1.47B | $1.71B | $1.01B | $1.56B | $1.42B | $1.67B | $322.30M |
| Capital Expenditure | $-227.52M | $-88.90M | $-19.47M | $-206.58M | $-7.78M | $-876.60M | $-1.51B | $-311.34M | $-158.12M | $-127.99M |
| Free Cash Flow | $2.79B | $2.16B | $2.04B | $1.26B | $1.71B | $130.33M | $50.20M | $1.11B | $1.52B | $194.31M |